
ISONIAZID AND NRTIS
The clearance of isoniazid is approximately doubled by zalcitabine, and there is a theoretical increased risk of peripheral neuropathy.
Monitor concurrent use carefully to ensure isoniazid is effective, and because of the potential for additive peripheral neuropathy.
Monitor concurrent use carefully to ensure isoniazid is effective, and because of the potential for additive peripheral neuropathy.